News EU regulators back J&J's Zytiga in early prostate cancer use New use could give J&J drug edge over Pfizer's rival
News Robots don't improve prostate surgery outcomes, says study No differences found in urinary function, post-operative complications or days off work.
News NICE lifts restrictions on Ferring prostate cancer drug Decision followed a successful appeal by manufacturer.
Views & Analysis Pharma gets social: did digital opinion leaders shape NICE g... Digital Opinion Leaders as activists in healthcare decision making.
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
